No significant effect of the SLCO1B1 polymorphism on the pharmacokinetics of ursodeoxycholic acid

Organic Anion Transporting Polypeptide 1B1: a Genetically Polymorphic Transporter of Major Importance for Hepatic Drug Uptake

(2011) M. Niemi et al.   PHARMACOLOGICAL REVIEWS

Pharmacological treatment of biliary cirrhosis with ursodeoxycholic acid

(2010) Ghulam Abbas et al.   EXPERT OPINION ON PHARMACOTHERAPY

Xenobiotic, Bile Acid, and Cholesterol Transporters: Function and Regulation

(2010) C. D. Klaassen et al.   PHARMACOLOGICAL REVIEWS

High performance liquid chromatography–tandem mass spectrometry for the determination of bile acid concentrations in human plasma

(2009) Xiaoqiang Xiang et al.   JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES

Effect of SLCO1B1 polymorphism on the plasma concentrations of bile acids and bile acid synthesis marker in humans

(2009) Xiaoqiang Xiang et al.   Pharmacogenetics and Genomics

Hepatic Nuclear Factor 1  Inhibitor Ursodeoxycholic Acid Influences Pharmacokinetics of the Organic Anion Transporting Polypeptide 1B1 Substrate Rosuvastatin and Bilirubin

(2008) Y.-J. He et al.   DRUG METABOLISM AND DISPOSITION